Aquatic Capital Management’s Arcus Biosciences RCUS Stock Holding History

Aquatic Capital Management’s Portfolio RCUS Stock Details RCUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$330K	Sell	15,297 -12,707	-45%	-$274K	0.01%	875
2025 Q4	$667K	Buy	+28,004	New	+$571K	0.02%	660
2024 Q4	–	Sell	-3,600	Closed	-$55K	–	1562
2024 Q3	$55K	Sell	3,600 -2,200	-38%	-$34.7K	﹤0.01%	989
2024 Q2	$88.3K	Buy	+5,800	New	+$93.6K	﹤0.01%	919
2023 Q4	–	Sell	-7,800	Closed	-$140K	–	1573
2023 Q3	$140K	Buy	+7,800	New	+$157K	0.01%	761
2023 Q1	–	Sell	-9,400	Closed	-$194K	–	1672
2022 Q4	$194K	Buy	+9,400	New	+$259K	0.01%	743

Other funds holding RCUS

Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Aquatic Capital Management's RCUS Position: Q1 2026 in Review

Aquatic Capital Management reduced its Arcus Biosciences (RCUS) stake by 45% in Q1 2026, selling an estimated $274K and leaving 15,297 shares worth $330K. The position accounts for 0.01% of the portfolio, ranked #875.

Aquatic Capital Management first reported a position in RCUS in Q4 2022 and has held it in 6 quarters since. The position peaked at $667K in Q4 2025. 210 funds tracked by Wall St. Rank hold RCUS as of Q1 2026.

Aquatic Capital Management held 15,297 shares of Arcus Biosciences worth $330K as of Q1 2026.
Aquatic Capital Management sold 12,707 Arcus Biosciences shares in Q1 2026, an estimated $274K.
Arcus Biosciences made up 0.01% of Aquatic Capital Management's portfolio in Q1 2026, its #875 holding.
Aquatic Capital Management first reported a position in Arcus Biosciences in Q4 2022 and has held it in 6 quarters since.
Aquatic Capital Management's Arcus Biosciences position peaked at $667K in Q4 2025.
210 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2026.

Based on Aquatic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.